Muscle-Building Pills Could Transform Aging and Fitness
Several experimental drugs targeting the protein myostatin are in clinical trials, aiming to prevent age-related muscle loss and enhance growth. Research tracing back to the 1990s showed that blocking myostatin in mice produced muscles two to three times normal size, and similar mutations occur naturally in some cattle and dogs. If successful, these treatments could help older adults maintain mobility and independence.
Related stories
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “Will muscle-boosting meds be the next big thing after GLP-1 drugs?.” Browse more stories.